When to Worry About a Sunburn, Mole or Skin Bump: An Expert Skin Cancer Guide

Key Highlights
Introduction
How ultraviolet radiation damages skin and raises cancer risk
Recognizing the red flags: what to watch for with sunburns, moles and bumps
Immediate steps: first aid for sunburn and what to do when you spot a suspicious lesion
How clinicians decide: diagnosis and the role of dermatoscopy, digital monitoring and biopsy
Treatment options explained: what to expect from minor to major interventions
When to remove a mole versus when to monitor
Prevention and practical sun-protection measures that work
High-risk patients: who needs closer surveillance
Misconceptions and common patient questions
How primary care and specialist services coordinate
Real-world stories: common clinical lessons
Practical checklists you can use
The healthcare system perspective: why early detection matters economically and medically
Looking ahead: research, new tools and what clinicians are watching
FAQ

Key Highlights

Persistent or changing lesions, blistering or systemic sunburns, and new lumps that grow or bleed are reasons to seek medical assessment; early detection of skin cancer greatly improves outcomes.
GPs use visual inspection, dermatoscopy, digital mole mapping and, when necessary, excisional biopsy to diagnose suspicious lesions; treatments range from simple excision to Mohs surgery and systemic therapies for advanced melanoma.
Daily sun protection, regular self-exams, and clear thresholds for when to consult a clinician can prevent many cancers and catch others at a curable stage.

Introduction

A summer day and a little sun can brighten moods — and, over years, the skin. Most returns from the beach with a tan or a transient burn and thinks little of it. The question that troubles patients and clinicians alike is more precise: when does a sunburn become a medical problem? When is a mole, freckle or little bump on the skin a routine blemish and when is it an early cancer that requires prompt treatment?

Dr David Hassan, a vocationally registered general practitioner with more than 16 years’ clinical experience and a decade devoted to skin cancer medicine, sees answers to those questions every day. He is a founding member of SunDocs, a clinic network established to make expert skin cancer services accessible locally. Clinical practice in primary care handles most initial assessments of suspicious lesions; correct triage and timely referral save lives and spare patients unnecessary procedures.

The following is a practical, evidence-informed guide to recognizing the signs that warrant concern, understanding the diagnostic pathway you will likely encounter in primary care, knowing what treatment options mean, and adopting daily habits that reduce long-term risk. Real-world clinical scenarios illustrate common pitfalls and sensible responses.

How ultraviolet radiation damages skin and raises cancer risk

Ultraviolet (UV) radiation from the sun and tanning devices damages DNA in skin cells. The body repairs much of this damage, but repetitive or intense UV exposure overwhelms repair mechanisms and increases the chance that a cell will accumulate mutations that drive uncontrolled growth.

Two patterns of UV exposure matter clinically. Intermittent intense exposure that causes blistering burns — particularly in childhood and adolescence — is strongly associated with melanoma risk. Chronic, cumulative exposure over years and decades tends to drive squamous cell carcinoma (SCC) and actinic keratoses, the latter being precancerous changes visible as rough, scaly patches. Basal cell carcinoma (BCC), the most common skin cancer, also relates to UV exposure but has a different natural history and tends to remain local unless neglected.

Skin type moderates risk but does not eliminate it. Fair skin that burns easily, freckling, many nevi (moles), a personal or family history of melanoma, and certain genetic syndromes increase the probability of malignant transformation. However, people with darker skin types can and do develop skin cancer, often in less sun-exposed areas, so vigilance remains necessary across populations.

Understanding the biological mechanism helps explain the clinical picture: cancers originating from melanocytes (melanoma) often manifest as pigmented lesions that change in color, shape or size. Keratinocyte cancers (BCC, SCC) arise from the outer epidermis and often present as non-pigmented nodules, persistent scabs, ulcers or rough patches.

Recognizing the red flags: what to watch for with sunburns, moles and bumps

Patients bring a wide range of concerns: "Is this mole new?" "Should I worry about my sunburn?" "This lump bleeds sometimes." Sorting urgent from routine takes attention to specific features.

Sunburns

Immediate red flags: blistering over a large surface area, severe pain, fever, nausea, lightheadedness or signs of dehydration. These warrant urgent medical advice because they indicate deep skin damage and systemic involvement.
Long-term concern: repeated blistering burns, especially in childhood, contribute to melanoma risk later in life. One severe childhood burn has been linked to an increased risk; repeated burns amplify that risk.
Healing pattern: normal sunburn resolves over days to a couple of weeks. Scalp burns, or burns that result in persistent ulceration or pigmented scarring, should be assessed.

Moles and pigmented lesions (melanocytic lesions)

ABCDE is a helpful rule-of-thumb for melanoma:
- Asymmetry — one half does not match the other
- Border— irregular, scalloped or poorly defined
- Colour — varying shades of brown, black, blue, white or red within the same lesion
- Diameter — while >6 mm is conventionally flagged, smaller melanomas occur
- Evolving — any change in size, shape, colour, elevation, or new symptoms such as bleeding, itching or crusting
Ugly duckling sign: a lesion that looks different from an individual's other moles often signals the need for review.
New growth in adulthood: new moles after age 40 deserve evaluation.

Bumps, nodules and non-pigmented lesions

Basal cell carcinoma typically appears as a pearly or translucent nodule with small visible blood vessels (telangiectasia), often on sun-exposed sites like the face. It may crust and bleed but usually grows slowly.
Squamous cell carcinoma often presents as a firm, scaly, or ulcerated lesion that can crust or bleed and may be tender. High-risk SCCs are fast-growing, painful, or arise from a chronic scar or long-standing actinic keratosis.
Non-healing wounds: any sore or scab that does not heal within 3–4 weeks should be evaluated.
Rapid growth, tenderness, night pain, fixation to underlying tissues, or regional lymph node enlargement are features that raise concern for aggressive behavior.

Subtle symptoms that matter

New or persistent itch confined to a lesion, a spot that intermittently bleeds without apparent trauma, or progressive thickening beneath a scar are all reasons to seek assessment.
Changes in sensation—numbness or pins and needles around a lesion—are less common but warrant evaluation.

These are clinical triggers used by Dr Hassan and many other skin cancer clinicians when triaging patients. The threshold for urgent referral is lower when the lesion has multiple worrying features.

Immediate steps: first aid for sunburn and what to do when you spot a suspicious lesion

Sunburn first aid

Cool the skin gently with cool (not cold) water; soak or cool compresses reduce pain.
Avoid breaking blisters deliberately. If blisters rupture, keep the area clean and covered to reduce infection risk.
Use simple analgesia such as paracetamol or ibuprofen for pain and inflammation, unless contraindicated.
Rehydrate; severe burns can cause systemic fluid loss.
For extensive blistering, high fever, or feeling faint, seek urgent medical attention. Young children, older adults and people with significant comorbidities should be assessed sooner.
Avoid applying oily substances to fresh burns that are blistered; they can trap heat.
Once acute inflammation eases, gentle moisturization supports barrier repair.

When you notice a suspicious lesion

Photograph it with a dated, close-up image and a second photo that shows its location on the body. Repeat intervals of photography are useful for tracking change.
Avoid "wait and hope" for lesions that are changing, bleeding, or failing to heal; book a primary care appointment.
Tell your clinician about any rapid growth, sudden colour or texture change, bleeding, or symptoms such as pain or itching. Mention family history of melanoma or prior skin cancers.
If possible, attend appointments with unmade-up skin and wear clothing that allows easy inspection of the area. Some clinics offer total body photography and mole-mapping services for high-risk patients.

Triage pathways in primary care vary. Many GPs perform dermatoscopy during the consultation — a quick, non-invasive examination with a handheld device that magnifies and illuminates the lesion. Dermatoscopy improves diagnostic accuracy and informs the decision to monitor, biopsy or refer.

How clinicians decide: diagnosis and the role of dermatoscopy, digital monitoring and biopsy

Initial consultation The clinical history and visual inspection form the backbone of triage. Clinicians ask about duration, changes, symptoms, personal and family history, sun exposure, and prior skin cancer. Decision-making then follows a pattern: reassure and monitor, perform a biopsy, or refer urgently.

Dermatoscopy

Dermatoscopy (also called dermoscopy) uses a magnifying lens and polarized light to reveal subsurface structures. It helps distinguish benign lesions (like simple moles and seborrhoeic keratoses) from lesions suspicious for melanoma or keratinocyte carcinomas.
Training and experience influence accuracy. In skilled hands, dermatoscopy reduces unnecessary excisions and increases early detection of melanoma.

Digital mole mapping and total body photography

For patients with many moles, atypical nevi or a strong family history, digital monitoring creates a baseline. Images are compared over time to detect subtle changes.
Short-term digital follow-up (3 months) is useful when a lesion shows some worrying features but not enough to justify immediate removal. Long-term annual monitoring applies to stable patients.
Mole mapping is particularly valuable for people with dozens or hundreds of moles — the "context" of each lesion helps identify the "ugly duckling."

Biopsy and histology

Excisional biopsy: removal of the entire lesion with narrow margins is preferred when melanoma is suspected. Complete removal allows accurate measurement of tumor thickness (Breslow depth), which determines staging and further management.
Incisional or punch biopsies may be used when lesions are large or in cosmetically sensitive areas, but they risk underestimating depth. For non-melanoma lesions, shave or punch biopsies are common.
Biopsy provides a definitive histopathological diagnosis. Pathologists report features such as tumor type, depth, margins, differentiation, perineural invasion and involvement of lymphovascular structures — all of which guide treatment.

Referral decisions

Urgent referral is typical for suspected melanoma and for high-risk SCC (rapid growth, deep invasion, perineural involvement, recurrent disease).
Low-risk BCCs or SCCs on low-risk sites may be managed in primary care with complete excision if the clinician has surgical skills and appropriate resources.
Specialist surgical teams or dermatologists manage complex lesions on the face, recurrent tumors, or when reconstruction is likely.

Treatment options explained: what to expect from minor to major interventions

Early, localized cancers often have straightforward curative options. Choice of therapy depends on tumor type, size, location, patient factors and available expertise.

Surgical excision

Standard treatment for melanoma and many non-melanoma skin cancers. Melanoma requires wide local excision with margins based on tumor thickness to reduce the risk of local recurrence.
Excision provides a cure for most early lesions. Reconstruction of the defect can range from simple suturing to skin grafts or local flaps for larger defects on the face.

Mohs micrographic surgery

Mohs surgery removes the tumor with minimal margins while examining 100% of the peripheral and deep margins in real time. It yields the highest cure rates and conserves tissue, making it ideal for high-risk or cosmetically sensitive areas such as the nose, eyelids, ears and lips.
Particularly useful for recurrent BCCs or SCCs and for tumors with ill-defined clinical margins.

Destructive therapies

Curettage and electrodesiccation: scraping away the tumor followed by cautery. Appropriate for well-defined, superficial BCCs on non-critical sites; less suitable for lesions where depth and margin control are essential.
Cryotherapy: liquid nitrogen freezes superficial lesions, often used for actinic keratoses and small superficial skin cancers.
Photodynamic therapy and topical agents (imiquimod, 5-fluorouracil): options for superficial BCCs, actinic keratoses and field cancerization where multiple precancerous lesions are present. They are non-surgical and can preserve cosmesis but require longer treatment courses and careful selection.

Management of SCC with higher metastatic potential

High-risk SCC often requires wider excision, possible sentinel lymph node biopsy or regional nodal imaging, and multidisciplinary discussion. If nodal spread occurs, surgery and radiotherapy may be necessary; systemic therapy is reserved for distant metastases.

Melanoma-specific therapy

Early-stage melanoma: wide excision often suffices. For tumors above a certain thickness threshold (commonly around 0.8–1.0 mm) clinicians discuss sentinel lymph node biopsy to check for microscopic spread to regional lymph nodes.
Advanced melanoma: immunotherapy agents (checkpoint inhibitors such as anti-PD1 drugs) and targeted therapies for tumors with BRAF mutations have transformed outcomes. These systemic treatments are administered and monitored by oncologists and can control disease for extended periods in patients with advanced disease.

Follow-up and surveillance

After removal of melanoma or high-risk non-melanoma cancers, clinicians schedule regular follow-up for skin checks and, when appropriate, imaging or nodal surveillance.
For patients with multiple lesions or high lifetime risk, regular GP or dermatology review combined with self-examination and digital imaging supports early detection.

Real-world example: how a common case progresses A 52-year-old outdoor worker notices a small pearly bump on his cheek that has occasionally bled. He delays seeking advice for months. When he attends his GP, the lesion looks like a classic nodular BCC. The GP excises it with narrow margins under local anesthesia. Histology confirms BCC with clear margins. The patient returns for a check at three months and then annually. Early diagnosis prevented a larger facial surgery and achieved a cosmetic and curative outcome.

Contrast that with a different case: a 28-year-old notices a changing dark mole on his shoulder. He brings a photo showing rapid enlargement and color change over six weeks. The GP performs an excisional biopsy; pathology returns as melanoma with a Breslow depth of 1.2 mm. The patient is referred urgently to a multidisciplinary melanoma service for wide local excision and sentinel node biopsy. Because of timely presentation, surgery is potentially curative. The difference between the two scenarios is timing and lesion type; both illustrate how early attention alters pathways and outcomes.

When to remove a mole versus when to monitor

Not every mole needs removal. Unnecessary excisions create scars and anxiety. Clinicians balance risks and benefits using history, dermatoscopy and, when available, digital imaging.

Remove if:

The lesion meets melanoma criteria (ABCDE) or is the ugly duckling.
A lesion is symptomatic — bleeding, itching, painful — with no benign explanation.
The lesion is changing rapidly.
There is uncertainty after dermatoscopy and the most reliable step is removal for histological diagnosis.

Monitor if:

The lesion is stable and benign-looking on dermatoscopy.
Multiple atypical nevi are present; monitoring with mole mapping helps identify change rather than removing every lesion.
The cosmetic consequences of removal outweigh the risk and careful surveillance is feasible.

Shared decision-making with the patient is central. A clinician should document rationale and the monitoring schedule if choosing observation.

Prevention and practical sun-protection measures that work

Prevention reduces the future burden of skin disease. Evidence supports a layered approach rather than a single intervention.

Sunscreen

Choose a broad-spectrum sunscreen with SPF 30 or higher. Apply generously: approximately 2 mg/cm2 of skin, which translates to about a shot-glass (20–30 mL) for full-body application in adults.
Reapply every two hours and after swimming or heavy sweating. Many people apply insufficient quantities and skip reapplication.
Use physical measures too: clothing, hats and shade lower UV exposure and compensate for imperfect sunscreen usage.

Clothing and timing

Wear tightly woven fabrics, long sleeves and a broad-brimmed hat when practical. UV-protective clothing with a high UPF rating offers reliable protection for outdoor work and recreation.
Avoid peak UV hours when UV intensity is highest — typically late morning to mid-afternoon. Seek shade and plan outdoor activities for early morning or late afternoon.

Behavioral measures

Do not use tanning beds. Artificial tanning devices emit concentrated UV radiation and increase melanoma and keratinocyte cancer risk.
Teach children sun-safe behaviours early. Protecting young skin reduces lifetime risk.

Occupational controls

For workers with prolonged outdoor exposure, employers should implement sun-protection policies: shaded rest areas, schedule adjustments, and provision of protective clothing and sunscreen.

Vitamin D considerations

Sun protection does not inevitably cause deficiency. Brief, incidental sun exposure and dietary sources generally maintain adequate vitamin D levels for most people. When concerns arise, test and supplement under medical advice rather than exposing skin deliberately to UV for vitamin D.

High-risk patients: who needs closer surveillance

Certain groups require heightened attention and structured follow-up.

Personal history of melanoma or multiple non-melanoma skin cancers.
Strong family history of melanoma or known pathogenic germline mutations (e.g., CDKN2A).
Numerous (>50) nevi, especially dysplastic nevi.
Organ transplant recipients and patients on long-term immunosuppression—they have a much higher risk of SCC and need frequent skin checks.
Genetic or medical syndromes that predispose to skin cancer.
Previous significant UV-induced skin damage: actinic keratoses, chronic ulcers, or radiation scars.

High-risk patients benefit from scheduled dermatology reviews, education on self-examination, and, when appropriate, digital monitoring and photodocumentation.

Misconceptions and common patient questions

Several myths recur in clinics and the media. Addressing them clarifies simple measures and reduces anxiety.

Sunscreen causes vitamin D deficiency

Short, incidental sun exposure and dietary sources generally maintain adequate vitamin D. When risk of deficiency exists, blood testing and measured supplementation are safer than deliberately foregoing sun protection.

Only fair-skinned people get skin cancer

Risk is higher in fair-skinned individuals, but skin cancer occurs across skin types. In darker skin types, cancers may appear in less-exposed areas such as the palms, soles or under nails, and often present later—making vigilance essential.

All moles are dangerous

Most moles are benign. The clinical task is to recognize the minority that change or have suspicious features.

If a biopsy shows a thin melanoma, no further treatment is needed

Thin melanomas are often cured by wide local excision, but staging (including consideration of sentinel node biopsy, depending on depth) and follow-up remain important.

Removing moles causes cancer to spread

Excision for diagnosis or treatment does not cause spread. The key is timely assessment and appropriate biopsy technique for suspected melanoma — excisional biopsies are preferred to capture full depth.

How primary care and specialist services coordinate

Primary care is the most common entry point for patients with skin concerns. GPs trained in skin cancer medicine perform the triage, dermatoscopy and minor surgical procedures. Clear communication between GPs and specialists accelerates care for patients with suspected advanced disease.

Typical pathway:

Patient notices lesion and books with GP.
GP assesses, performs dermatoscopy and may photograph the lesion.
If melanoma is suspected: excisional biopsy or urgent referral to a melanoma clinic; staging and surgical planning follow.
If non-melanoma cancer is suspected and suitable for local management: GP may excise or refer to a skin cancer clinic or surgeon.
MDT (multidisciplinary team) meetings discuss complex cases, especially high-risk SCC and melanoma with nodal involvement.

Access varies by region. Networks like SunDocs aim to expand availability of trained clinicians and rapid-access pathways for timely assessment.

Real-world stories: common clinical lessons

Case 1: The delayed sunburn that mattered A woman in her late 60s presented after repeatedly dismissing a scaly patch on her temple as a “dry spot.” By the time she sought help it had become a firm, ulcerated lesion. Histology showed invasive SCC. Her outcome was positive because the lesion had not yet spread to lymph nodes, but the surgery was larger than it would have been if managed earlier. Lesson: persistent scaly patches on sun-exposed sites merit early evaluation.

Case 2: The mole that changed A 35-year-old man photographed a new mole that had darkened and grown over two months. The GP performed an excisional biopsy; pathology revealed melanoma. Early referral allowed sentinel node staging and a surgery that likely prevented spread. Lesson: new or rapidly changing pigmented lesions in adults should prompt immediate review.

Case 3: The workplace with a prevention plan A landscaping company implemented a sun-safety program: shade structures, mandatory hats and provision of SPF 50 sunscreen. Over five years, the company reported fewer sunburn incidents and encouraged workers to seek skin checks. Lesson: coordinated workplace policies reduce acute sun damage and help with long-term prevention.

These anonymized vignettes reflect patterns seen by clinicians like Dr Hassan: timely recognition alters management and outcomes.

Practical checklists you can use

Self-exam checklist (monthly)

Stand in front of a mirror: examine face, neck, chest, arms, hands.
Use a hand mirror for scalp, back, buttocks, backs of legs and feet.
Check between toes, under nails, and the genital area.
Note any new lesion, asymmetric mole, change in colour, increase in size or a spot that bleeds or itches.
Photograph new or changing lesions and show them to your clinician.

What to tell your GP

How long you’ve had the spot and what you observed (size change, colour change, symptoms).
Previous sunburns, tanning bed use, personal/family history of melanoma.
Photographs that show change over time.

When to seek urgent assessment

Rapidly changing pigmented lesion.
New lesion that bleeds, crusts, or won’t heal after three weeks.
Large-area blistering sunburn, high fever, fainting or severe pain.
New lump with rapid growth or associated lymph node enlargement.

The healthcare system perspective: why early detection matters economically and medically

Detecting skin cancers early reduces morbidity and healthcare costs. Early excisions for BCCs and thin melanomas are curative and far less expensive than advanced-stage treatments requiring complex surgery, radiotherapy, systemic therapy or prolonged hospitalization.

Primary care and community clinics play a crucial role in catching disease early. Training GPs in dermatoscopy and minor surgical competence, along with accessible referral pathways to dermatology and surgical oncology, strengthens the system’s capacity to manage increasing demand.

Public health measures—sun-safety education in schools, occupational regulations, campaigns during high-UV seasons—reduce population-level risk. For countries with high UV exposure, such measures are central to cancer control strategies.

Looking ahead: research, new tools and what clinicians are watching

Diagnostic technologies continue to evolve. High-resolution teledermoscopy, AI-assisted triage tools and integrated digital mole mapping promise to assist clinicians by flagging suspicious lesions for priority review. However, technology supplements rather than replaces a careful clinical examination and patient history.

Treatment advances in oncology, especially immunotherapy and targeted therapy for melanoma, have changed prognoses for advanced disease. Research into predictive biomarkers, combination therapies and earlier detection strategies continues to refine practice.

Clinicians emphasize that while promising, new tools require rigorous validation, appropriate governance and careful integration into clinical workflows to avoid over-referral and false reassurance.

FAQ

Q: When should I go to the emergency department for a sunburn? A: Seek urgent care if you have widespread blistering, signs of systemic illness (high fever, persistent vomiting, confusion, fainting), severe pain unresponsive to oral analgesia, or if the patient is a young child, elderly or has significant comorbidities. Simple sunburns without systemic symptoms are managed at home with cooling, analgesia and fluids.

Q: How long should I wait before seeing a GP about a suspicious mole? A: If a lesion is changing rapidly, bleeding or symptomatic, see a GP as soon as possible. If it is a new mole in an adult that shows change, or a lesion that doesn’t heal in three to four weeks, book a consultation without delay.

Q: Does removing a mole spread cancer? A: No. Surgical removal for diagnosis or treatment does not disseminate cancer. Excisional biopsy is the recommended approach for suspicious pigmented lesions because it provides full-depth tissue for accurate diagnosis.

Q: How often should I perform a self-skin check? A: Monthly self-examinations are practical for most people. High-risk individuals may benefit from more frequent checks or professional skin examinations every 3–12 months, depending on risk level.

Q: Are sunscreens enough to prevent skin cancer? A: Sunscreen is a key component but not the sole solution. Combine sunscreen with physical barriers (clothing, hats), shade-seeking and behavioural choices (avoiding peak UV hours). Correct application and reapplication are essential to achieve protection.

Q: What does dermatoscopy do and why does it matter? A: Dermatoscopy magnifies and illuminates lesions, revealing structures invisible to the naked eye. It increases diagnostic precision and helps clinicians decide whether to monitor or remove a lesion.

Q: If I have a family history of melanoma, what should I do? A: Tell your GP. You may need regular dermatology follow-up, education about self-examination, and possibly digital mole mapping. Some families with strong histories are referred for genetic counselling and testing where appropriate.

Q: How are suspicious lesions biopsied? A: For suspected melanoma, an excisional biopsy removing the whole lesion with narrow margins is preferred. For non-melanoma lesions, shave or punch biopsies may be used to obtain diagnostic tissue. Your clinician will explain the method that best suits the lesion and location.

Q: Can skin cancer recur after removal? A: Yes. Local recurrence is possible if margins are positive or if there is aggressive histology. Regular follow-up and self-examination reduce the risk of delayed detection.

Q: What are the signs of high-risk squamous cell carcinoma? A: Rapid growth, size >2 cm, depth >2 mm, poor differentiation on pathology, perineural invasion, location on the lip or ear, or arising in chronic ulcers or scars. High-risk SCC warrants specialist management.

Q: Are there treatments for advanced melanoma? A: Yes. Modern systemic treatments, including immune checkpoint inhibitors and targeted therapies for BRAF-mutated tumors, have substantially improved outcomes. Multidisciplinary oncology care is essential for advanced disease.

Q: Is mole-mapping available to most people? A: Access varies. Many dermatology clinics and some GP practices offer digital mole mapping; others refer to specialist services. Discuss availability with your healthcare provider if you have many moles or a strong family history.

Q: Should I avoid all sun exposure? A: Complete avoidance is impractical and unnecessary. Aim for sensible sun protection: limit peak UV exposure, use sun-protective clothing, and apply sunscreen correctly. Discuss vitamin D concerns with your clinician rather than seeking unprotected exposure.

Q: What if I can’t afford specialist care? A: Many regions provide skin cancer clinics, community dermatology services or public hospital pathways for urgent referrals. Primary care clinicians can perform initial assessment and, where appropriate, definitive treatment. Ask your GP about public options and possible prioritization.

Q: How accurate are online or app-based skin checks? A: Some tools assist patients in tracking lesions, but accuracy varies. They are not a substitute for clinician assessment, particularly for lesions that are changing or symptomatic. Use them as adjuncts, not replacements.

Q: Does getting older increase my skin cancer risk? A: Yes. Cumulative UV exposure over time raises risk of keratinocyte cancers and melanoma incidence increases with age, though melanoma can occur at any adult age. Regular checks become more important as people age.

Q: How do I know if a scar after removal is normal? A: Healing evolves over weeks to months. A scar that remains red or lumpy, shows widening, becomes painful, or has recurrent breakdown merits follow-up. Cosmetic revision is sometimes possible once healing is complete.

Q: What are actinic keratoses, and do they need treatment? A: Actinic keratoses are rough, scaly patches caused by chronic sun damage and are precancerous. Treatment options include cryotherapy, topical agents and photodynamic therapy. Treating them reduces the risk of progression to SCC.

Q: Can I prevent all skin cancer? A: No. While prevention reduces risk, not all cancers are preventable. The combination of prevention, regular surveillance and prompt treatment offers the best protection against morbidity and mortality.

Skin cancers and sun damage present a spectrum of clinical scenarios from trivial to life-threatening. Recognizing red flags, seeking timely medical evaluation, and adopting consistent sun-protective behaviours change outcomes. Primary care clinicians, often supported by dermatoscopy and digital tools, play a central role in early detection. For those at higher risk, structured surveillance and easy access to specialist care are crucial. If a mole, sunburn or skin bump concerns you, a prompt conversation with your GP is the best next step.